A lecture under the auspices of the Cancer Commission of Harvard University, Feb. 25, 1909. Select the format you want to export the citation of this publication.
Since 2013, 58 patients with histologic and/or serum and CSF tumor marker evaluations of primary intracranial germ cell tumors were diagnosed; 43 were germinoma with HCGβ levels ≤200 mIU/mL and five ...
Ivonescimab alone or combined with chemotherapy led to intracranial responses among 34% of patients with brain metastases at baseline – 23% achieved a complete response All patients who did not ...
Hosted on MSN
Magnetically-driven innovative solution developed for personalized intracranial tumor therapy
Brain tumors remain among the most challenging conditions in modern medicine. Due to their complexity and location, many of them are difficult to access, even with the most advanced surgical and ...
A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in ...
Development and validation of a clinical risk score for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO Resect group. This is an ASCO Meeting Abstract from the 2024 ASCO ...
Depot medroxyprogesterone acetate use was tied to higher meningioma risk in a large U.S. study. Other contraceptives, including IUDs and combined oral pills, showed no increased meningioma risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results